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Abstract                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 34 
The epidemiology of hepatitis C virus varies widely across geographic regions and 35 
ethnic groups.  Our previous study showed that 6 strains isolated from Baisha County, 36 
Hainan Island, China were all new genotype 6 (gt6) subtypes which differed 37 
significantly from subtypes of other regions.  In the current study, we conducted a 38 
comprehensive epidemiological survey of HCV in the Li ethnic group, native to Baisha 39 
County. Anti-HCV antibodies were detected by 2 independent ELISAs in all 40 
participants, positive results confirmed by the recombinant immunoblot assay (RIBA) 41 
and HCV RNA viral loads were measured.  Univariate chi-square test and 42 
multivariable logistic regression analyses were used to determine the risk factors for 43 
HCV infection and spontaneous clearance rates.  Indeterminate RIBA results were 44 
excluded or included in analyses, consequently findings were expressed as a range. 45 
Direct sequencing of partial regions within NS5B and E1 were employed for 46 
genotyping.  Among 1682 participants, 117 to 153 were anti-HCV positive (7.0-9.1%), 47 
with 42.7-52.6% confirmed to have cleared infection.  Anti-HCV positivity was 48 
associated with older age (≥60years) (OR=0.02, 95%CI 0.01-0.05, P<0.01) and 49 
surgery (OR=2.75, 95%CI 1.36-5.57, P<0.01), with no significant difference found 50 
between the HCV infection group and the HCV spontaneous clearance group. The gt6 51 
subtype distribution characteristics of Baisha County were unique, complex and diverse. 52 
The sequences did not cluster with known gt6 subtypes but formed 4 Baisha 53 
community-specific groups. HCV infection in members of the Li minority ethnic group 54 
is characterized by high prevalence rates in the elderly, high spontaneous clearance rates 55 
and broad gt6 diversity. 56 
 57 
Key words: Hepatitis C; Seroprevalence; Risk factors; Li minority; Genotype  58 
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Introduction 59 
 60 
Hepatitis C virus (HCV) is a blood-borne virus that is a major cause of end-stage 61 
liver diseases, including decompensated cirrhosis and hepatocellular carcinoma.  62 
Approximately 6-40 million Chinese people are HCV antibody positive (anti-HCV+), 63 
with a general prevalence of 0.43% to 3.2%1-3.  Recent reports from the Chinese 64 
Ministry of Health showed that the number of new HCV infections increased from 65 
39,380 cases in 2004 to 214,023 cases in 2017 (http://en.nhfpc.gov.cn/).  Currently, 66 
there is no vaccine against HCV.  Even though new direct acting antivirals (DAAs) 67 
can achieve high sustained virology response (SVR) rates, they are extremely costly 68 
and emerging resistance-associated variants (RAVs) have been linked to DAA 69 
treatment4-7.  Prevention of new infections is therefore considered the most cost-70 
effective policy to reduce overall HCV prevalence in China8. 71 
 72 
The prevalence of HCV is distributed unevenly in different regions of China and 73 
among different populations.  Very high rates of HCV infection were often found in 74 
men who have sex with men (MSM) and in human immunodeficiency virus (HIV)-75 
infected people in recent years9,10.  Also, high HCV infection prevalence is often 76 
found in some remote regions of the country.  For example, HCV prevalence was as 77 
much as 9.6% in Linxian, a rural community in Henan Province of China11.   As 78 
reported, HCV is most frequently transmitted by certain medical and non-medical 79 
procedures12-15.  Understanding the prevalence and risk factors for HCV infection in 80 
regions with high prevalence could effectively prevent virus transmission to other 81 
geographical areas.  Following initial exposure to HCV, two outcomes can occur, 82 
either chronic infection or spontaneous clearance of the virus, which occurs in 15%-40% 83 
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of cases16-18.  Due to the fact that symptoms occur in only ~15% of HCV-infected 84 
patients19, the clearance rate may be underestimated. 85 
 86 
HCV has been classified into 7 genotypes according to genetic variation.  87 
Generally, gt1, gt2, and gt3 are distributed globally, gt4 is prevalent in Middle Eastern 88 
countries, gt5 is restricted to the northern part of South Africa20, and gt6 is endemic in 89 
Southeast Asia and south China21-24.  Previously, we conducted a comprehensive study 90 
25 and found that HCV gt6a has become the second most prevalent subtype on Hainan 91 
Island.  Other than HCV gt6a, we also identified 6 novel unassigned gt6 variants, all 92 
of which were discovered in the Li ethnic within Baisha County, Hainan Island26.  93 
Baisha County is located in a mountainous area on Hainan Island and most native 94 
residents belong to the Li ethnic minority that is derived from a sub-group of 95 
Austronesians who are descended from the aborigines of the Neolithic Age.  In order 96 
to understand whether the novel gt6 unassigned variants were an unusual phenomenon, 97 
we designed this study to understand the epidemiology of HCV infection in the Hainan 98 
Li ethnic community. Such information could help improve strategies for HCV 99 
prevention and control in this county and potentially avoid transmission to other regions 100 
of Hainan Island.  Moreover, it could give insight into the evolution of gt6 in the Li 101 
ethnic group.  102 
 103 
Material and methods 104 
 105 
Survey cohort 106 
 107 
From July 2014 to October 2015, 1682 volunteers from all 4 Baisha communes 108 
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and 7 townships aged 11-95 years were invited to participate in this study.  The 109 
participants were selected by a random sampling method, including adults who received 110 
health examinations and children in high school who received a thalassemia test.  The 111 
inclusion criteria were: 1) residing in the study locale, 2) having the cognitive ability 112 
required to respond to the questionnaire survey and 3) having no prior HCV treatment.  113 
The physicians ensured that individuals were personally interviewed to assure their 114 
complete understanding of the study and the participants provided written informed 115 
consent prior to enrollment.  People who refused to provide the detailed information 116 
contained in questionnaire survey forms were excluded from the study.  Participants’ 117 
socio-demographic features and the presence of risk factors were recorded and blood 118 
samples were collected for an assessment of HCV markers. This study was approved 119 
by the Medical Ethics Committee of Guangzhou Blood Center and conformed to the 120 
ethical guidelines of the 1975 Declaration of Helsinki. All study subjects signed an 121 
informed consent. 122 
 123 
Anti-HCV assays and HCV RNA detection 124 
 125 
The 1682 plasma specimens were tested for HCV antibody using two independent 126 
HCV enzyme-linked immunosorbent assays (ELISA) (Shanghai Kehua, China and 127 
Ortho HCV 3.0 ELISA, Ortho-Clinical Diagnostics, Inc, USA).  HCV RNA levels 128 
were tested by quantitative real-time polymerase chain reaction (qPCR) (Diagnostic Kit 129 
for Quantification of Hepatitis C virus RNA, Da An Gene Co, Ltd. of Sun Yat-Sen 130 
University, China) and the limit of detection (LOD) was 50 IU/ml.  The presence of 131 
HCV antibody was further confirmed by RIBA-HCV BLOT 3.0 (MP Biomedicals Asia 132 
Pacific Pte. Ltd., Singapore).  The RIBA-HCV BLOT 3.0 assay utilizes well-defined 133 
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antigens derived from HCV immunodominant proteins from core, NS3 helicase, NS4 134 
and NS5 regions.  Band reactivity was graded by visual calibration against the human 135 
immunoglobulin (IgG) control band (1+) and anti-IgG control band (3+).  A sample 136 
was considered positive when at least two HCV bands had a reactivity of ≥1 or a 137 
single core band had reactivity of ≥2.  Indeterminate results were defined when only 138 
a single band had a reactivity (except core reactivity of ≥2), and a result was 139 
considered negative when no single HCV antigen line had a reactivity of ≥1. 140 
 141 
Sequence determination 142 
 143 
HCV sequences from the E1 region [nucleotide (nt) 729 to 1322 according to the 144 
numbering of the H77 genome] and NS5B region (nt 8256 to 8641) were amplified 145 
following previously described protocols22.  Briefly, viral RNA was extracted using a 146 
QIAamp Viral RNA Mini Kit (QIAGEN Inc, Valencia, CA, USA).  Reverse 147 
transcription PCR (RT-PCR) was performed by RevertAid First Strand cDNA Synthesis 148 
Kit (Fermentas, CA, USA).  Amplification was completed by a nested PCR with E1 149 
or NS5B-specific primers22.  The amplified products were bi-directionally sequenced 150 
using an Applied Biosystems (ABI) PRISM Big Dye Terminator Cycle Sequencing 151 
Ready Reaction Kit, Version 3.1 (Applied Biosystems, Foster City, CA, USA).  The 152 
bi-directional sequences were inspected and assembled using SeqMan to obtain the 153 
consensus sequence.  Sequences were aligned using MegAlign.  The above software 154 
used is contained in the Lasergene 8.1 Package (DNASTAR Inc, Madison, WI). 155 
 156 
Phylogenetic analysis 157 
 158 
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Phylogenetic analysis was performed using MEGA 7.0.  The maximum 159 
likelihood approach (using the General Time Reversible model and Gamma distributed 160 
with Invariant site (G+I) rate) with 500 iterations of bootstrap sampling was performed.  161 
HCV genotype reference sequences were retrieved from the HCV database 162 
(http://hcv.lanl.gov/content/sequence/HCV/ToolsOutline.html).  Reference sequences 163 
in the phylogenetic analysis were chosen according to consistent criteria27 and HCV gt6 164 
unassigned sequences were included (detailed information is shown in Supplementary 165 
Table 1).  The significance of the tree topology was evaluated using the distance 166 
program (method: p-distance), implemented in Mega 7.0.  Bootstrap values of >70% 167 
were considered significant.   168 
 169 
Statistical analysis 170 
 171 
The Chi-square test and multivariate logistic regression analyseis were applied to 172 
determine the predictors of anti-HCV positivity.  Measurement data were expressed 173 
as the mean ± standard deviation (SD) and compared using the two-sample t-test, where 174 
appropriate.  P<0.05 was considered statistically significant.  All statistical analyses 175 
were performed with SPSS Statistics for Windows, version 19.0 (IBM Corp., Armonk, 176 
New York). 177 
 178 
Nucleotide sequence accession numbers 179 
 180 
The nucleotide sequences reported in this study were deposited in Genbank with 181 
the following accession numbers: MH298078-MH298132 and MH298133-MH298190. 182 
 183 
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Results  184 
 185 
HCV infection in the Baisha Li minority 186 
 187 
Samples from the 1682 Baisha Li subjects were tested for HCV antibodies, and 188 
324 were reactive (19.3%) based on the Ortho ELISA assay.  Reactive samples were 189 
retested with Kehua ELISA assay, and 249 (14.8%) were reactive with both 190 
independent assays.  HCV RNA was detected in 67 of these samples with a mean viral 191 
load of 6.76 x104 IU/ml ± 9.55 (Table 1).  No samples were found that were both anti-192 
HCV negative and HCV RNA positive (HCV RNA [+]).  When compared with the 193 
viral RNA titer (3.90 x105 IU/ml ± 6.92) in chronically HCV-infected subjects in China 194 
in our previous study28, the HCV RNA titer in the Li minority of Baisha County was 195 
significantly lower (t=20.79, d.f.=102, P<0.01, t test). 196 
 197 
We determined that positivity in both the HCV RNA test and 2 independent 198 
ELISAs was sufficient to confirm HCV infection and no further serological testing was 199 
performed for these 67 samples. For the remaining 182 seropositive samples that were 200 
HCV RNA negative [HCV RNA (-)], an anti-HCV confirmatory assay (RIBA) was used 201 
to further assess the presence of HCV antibodies.  Using RIBA, 96 of the 182 HCV 202 
ELISA (+) samples were determined to be negative and subsequently excluded from 203 
the anti-HCV positive group (Table 1).  Patients testing HCV RNA (+) (n=67) or 204 
RIBA positive (n=50) were defined as the anti-HCV (+) group. HCV RNA (+) 205 
individuals were considered as having a persistent infection whereas RIBA positive 206 
individuals but who were HCV RNA (-) were defined as spontaneous clearers. There 207 
were 36 RIBA indeterminate samples which were either included or excluded from 208 
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subsequent analysis to give both liberal and conservative estimates.  Using these 209 
criteria, the prevalence of HCV infection in the Baisha Li minority was 7.0-9.1% (n= 210 
[67+50]/1682 or [67+50+36]/1682).  Surprisingly, HCV prevalence varied greatly 211 
between subjects ≥60 years old and < 60 years old (Table 2).  Only 5 of the HCV (+) 212 
samples were from individuals < 60 years old.  The prevalence of virus infection for 213 
participants aged 60 or more was 16.4-21.6% (n=112/685, or 148/685 including RIBA 214 
indeterminate results), but only 0.5% (n=5/997) for those <60 years of age.  215 
Furthermore, we found that HCV spontaneous clearance was high (42.7-52.6%, 216 
n=50/117 or 86/153 minus or plus RIBA indeterminate results respectively) across the 217 
entire infected group.  In terms of the antigen reactivity of the 86 HCV RNA (-), RIBA 218 
(+) or indeterminate samples, a wide reactivity was observed with core antigen.  69 219 
samples (80.2%) reacted with core antigen, 65 (75.6%) reacted with NS3 antigen (NS3-220 
1 and NS3-2), 50(58.1%) with NS4 antigen and 12(14.0%) with NS5 antigen 221 
(Supplementary Table 2). 222 
 223 
Risk factors for hepatitis C 224 
 225 
The prevalence of HCV infection did not differ significantly by univariate analysis 226 
based on gender, transfusions, alcohol consumption, piercings, acupuncture, familial 227 
HCV infections or dental procedures, but did vary significantly for tattooing, surgery 228 
and age ≥60 years, both including and excluding the RIBA indeterminate samples 229 
(Tables 3 and 4). The results obtained by including or excluding RIBA indeterminate 230 
samples from the analysis were similar; only the inclusion group is shown below and 231 
details for the exclusion group are given in table 4. In the anti-HCV (+) group, there 232 
were more persons who had been tattooed and undergone surgery than in the anti-HCV 233 
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(-) group (OR=2.82, 95%CI 1.78-4.46, P<0.01; OR=4.05, 95% CI 2.18-7.51, P<0.01, 234 
overall chi-square test).  We also found that individuals aged ≥60 years had a 235 
significantly higher prevalence of HCV infection than people aged <60 years (OR=0.02, 236 
95% CI 0.01-0.05, P<0.01, chi-square test) (Table 3).  Multivariate logistic regression 237 
analysis revealed that an age≥60 years (OR=0.02, 95% CI 0.01-0.05, P<0.01) and 238 
surgery (OR=2.75, 95%CI 1.36-5.57, P<0.01) were the significant predictors of anti-239 
HCV positivity (Table 3) with the confounders adjusted. In addition, we found that there 240 
was no significant difference between HCV spontaneous clearance and HCV persistent 241 
infection for risk factors including gender and age, as well as history of transfusion, 242 
alcohol consumption, tattooing, surgery, piercings, acupuncture, a family history of 243 
HCV and dental operations (Supplementary Table 3). There was also no significant 244 
difference in the relative prevalence of persistent and recovered HCV infection 245 
according to gender, either excluding or including the RIBA indeterminate results 246 
(supplementary table 4).  247 
 248 
Molecular characterization of Baisha HCV strains 249 
 250 
In order to determine the HCV genotype/subtype distribution in the study subjects, 251 
we amplified and sequenced the 67 HCV RNA (+) samples.  55 sequences from the 252 
E1 region and 58 from the NS5B region were obtained, while neither E1 nor NS5B 253 
sequences were amplified from 8 samples because of their very low viral loads and 254 
limited plasma volume.  For these 8 samples, we tried to amplify the 5’UTR and Core 255 
regions, but only 1 sequence from the 5’UTR region was amplified which was 256 
determined as gt6new by phylogenetic analysis (data not shown). No amplified 257 
products were obtained from sample 114 in the NS5B region and samples 257, 292, 258 
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429 and 555 in the E1 region despite several attempts, suggesting a lack of primer 259 
specificity for these HCV strains which potentially represent new subtypes. Indeed all 260 
the amplified products in our analysis did not cluster clearly with any of the previously 261 
assigned gt6a-6xd or other unassigned gt6 variants which were collected from some 262 
south Asian countries such as Thailand, Vietnam, Cambodia, Laos and Myanmar23,29 263 
(Fig 1).  Interestingly, the NS5B Baisha sequences formed four specific groups 264 
(designatedⅠ,Ⅱ,Ⅲ and Ⅳ) which included 6 database sequences collected from 265 
Baisha County of Hainan Island and 1 database sequence obtained from the Guangdong 266 
province of China.  24.1% (14/58) of the Baisha strains clustered within groupⅠ, 19.0% 267 
(11/58) clustered with group Ⅱ, 36% (21/58) clustered with group Ⅲ and 15.5% 268 
(9/58) clustered with group Ⅳ, all with significant bootstrap values.  Isolates BSM397, 269 
371 and 396 were distinctly divergent from the above four groups and the gt6 reference, 270 
but their bootstrap values were lower than 70%. It should be noted that sequence 271 
homology between these three isolates and gt6 reference strains ranged between 61-272 
83%.  Full length viral genome sequencing is required to confirm their diversity in a 273 
future study.  Although the subtype 6w (EU643834, DQ278892) database sequences 274 
were the closest strains to group Ⅰ, these sequences cannot be considered as belonging 275 
to 6w because of high variability with the database strains (ranging between 19.4%-276 
22.9%), which is greater than the recognized within-subtype distance of 15%.  Six 277 
isolates (KJ470620, KJ470621, KJ470622, KJ470623, KJ470624, KJ470625; 278 
designated gt6new) that were previously collected from Baisha County clustered with 279 
groupⅡand Ⅲ.  The distance between KJ470623 and samples 9, 41, 46, 22, 239 and 280 
525 was 9.3%-12.4%, which is within the acceptable subtype range.  However at least 281 
one full-length (or at least complete open reading frame) is needed to designate a new 282 
subtype according to the HCV nomenclature criteria of the International Committee on 283 
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Taxonomy of Viruses (ICTV).  The distances between other database sequences and 284 
the Baisha sequences were greater than 15%.  Even KC844040, the gt6new sequence 285 
which was collected from Guangdong province of China that clustered with group Ⅳ, 286 
was 15%-19.3% distant from the group Ⅳ Baisha isolates, indicating that the Baisha 287 
sequences are divergent from all other current gt6 sequences.  To illustrate the 288 
diversity within the Baisha sequences, strains 282 and 305 were identified from a 289 
couple but clustered with different groups and the sequence divergence was 29%. No 290 
other participants within the study were related according to our questionnaire survey. 291 
 292 
We also analyzed E1 sequences using the same methodology as that for NS5B. 293 
The phylogenetic tree inferred by E1 sequences (Fig 2) had a similar topology to the 294 
NS5B phylogenetic tree.  All the E1 sequences in the current study also did not clearly 295 
cluster with any of the currently assigned gt6a-6xd subtypes or with unassigned gt6 296 
variants which were collected from some south Asian countries 23,29.  Similar to the 297 
results with NS5B, the E1 sequences demonstrated a trend and formed four specific 298 
groups (groupsⅠ,Ⅱ,Ⅲ and Ⅳ) although the bootstrap values of groupsⅠandⅡwere 299 
lower than 70%.  Full length viral genome sequencing is required to confirm the 300 
diversity of these two groups in a future study.  The sequences from the couple (strains 301 
282 and 305) that were divergent in the NS5B region also clustered with different 302 
groups in the E1 region.  303 
 304 
Characterization of highly divergent Baisha HCV viral strains 305 
 306 
In order to determine whether or not the high sequence divergence observed for 307 
samples 282 and 305 was the consequence of a complex mixture of multiple infections, 308 
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the E1 amplified product was cloned and 50 clones from each sample were sequenced 309 
and phylogenetically analyzed (Supplementary Fig 1).  Strain 409 was cloned and 310 
similarly sequenced as a control.  Within each sample tested, the cloned sequences 311 
were closely related, with a sequence homology of 99-100% for sample 282, 95-100% 312 
for 305 and 98-99% for 409.  Phylogenetic analysis showed that the cloned sequences 313 
for each isolate clustered together and with the corresponding PCR-derived sequence 314 
(Supplementary Fig 1).  When the cloned sequences were included in the E1 315 
phylogenetic analysis, the topology and bootstrap values were similar to those obtained 316 
with the PCR-derived consensus sequences (data not shown).  These data confirmed 317 
the genomic divergence of the strains from samples 282 and 305, indicating that this 318 
couple had been independently infected and sexual transmission can be excluded. 319 
 320 
Discussion 321 
In the current study, high HCV prevalence (7.0-9.1%), high spontaneous clearance 322 
rates (42.7-52.6%) and a broad gt6 diversity were observed in Baisha County, which is 323 
remarkably different from that observed in other regions.  The specific epidemiology 324 
resulting in such high divergence is unknown but may be indicative of transmission 325 
trends or specific HCV evolution.  326 
 327 
The prevalence of HCV in the Li minority of Baisha County in our study was 328 
between 7.0% and 9.1%, which is higher than previous reports in China (3.2% in 199230, 329 
2.2% in 19972, 0.43% in 20063 and 3.0% reported by a more recent study whose 330 
subjects were recruited in Jilin province from 2010 to 20131).  One reason for the 331 
varied HCV prevalence between studies was the testing procedures used, i.e. utilizing 332 
one or two ELISA screening assays, and whether a confirmatory assay (RIBA) was 333 
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applied.  For example, the 0.43% positive rate was based on the utilization of two 334 
ELISA screening assays plus RIBA1 whereas the 3.0% prevalence in Jilin province was 335 
based on two ELISA screening assays only3.  In our study, after performing two 336 
independent ELISA screening assays, we further employed a highly specific RIBA 337 
assay to exclude false positive reactions from the ELISA screening assays which have 338 
been reported to have up to 35% false-positive results in immunocompetent individuals, 339 
blood donors, the military and the general population31.  RIBA indeterminate results 340 
indicate that the clinical status of such individuals cannot be determined. Previous 341 
studies showed that a RIBA indeterminate test may be observed in recently infected 342 
individuals who are in the seroconversion phase or in elderly individuals who have 343 
recovered from previous or distant HCV infection32-34. Makuria et al33 reported that 344 
RIBA-indeterminate blood donors were older than chronic HCV carriers. All of the 345 
RIBA indeterminate individuals in our study were ≥60 years old and there is no other 346 
available RIBA assay to perform a second test. Therefore, we considered these RIBA 347 
indeterminate samples as both recovered and not recovered from infection in our 348 
calculations. Thus, the 7.0 to 9.1% prevalence of HCV infection in the Li minority 349 
group in this remote, rural county is relatively reliable.  Another likely reason for 350 
discrepancies between studies is the socio-demographics of the participants within each 351 
cohort, including geography and age.  Interestingly, HCV infection in the Baisha Li 352 
minority demonstrates a birth cohort effect, with 95.7-96.7% (n=[112/117]-[148/157]) 353 
of HCV infections occurring in individuals ≥60 years old and the prevalence rate in 354 
this age group was 16.4 to 21.6%.  Of the five infected individuals whose age was <60 355 
years old, four sequences (BSY159, BSY517, BSM217 and BSM694) had a scattered 356 
distribution among the elder age sequences (Fig 1 and Fig 2); the fifth was HCV RNA 357 
(-) and no viral sequences were obtained from PCR amplification.  Both univariate 358 
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Chi-square and multiple logistic regression analysis showed that age ≥60 years old 359 
was strongly associated with anti-HCV positivity.  We speculate that perhaps specific 360 
lifestyle behaviors or poor medical practices in the past led to HCV transmission in the 361 
Li ethic group from Baisha County.  Furthermore, surgery was an important risk factor 362 
for HCV infection both by univariate Chi-square and multiple logistic regression 363 
analysis, probably due to the use of unsterile devices, as demonstrated in previous 364 
studies35,36.  Another important risk factor was tattooing based on the results from the 365 
univariate Chi-square between HCV infection prevalence in tattooed verses non-366 
tattooed persons (Table 3 and 4).  Unsafe practices could have exposed individuals to 367 
contaminated tattooing tools because of a lack of awareness of infection control 368 
practices, lack of sterilization equipment, not purchasing disposable tattoo tools and so 369 
forth.  There is evidence that tattooing is a route for HCV transmission37,38.  The Li 370 
minority of Baisha County has reportedly had less contact with individuals from other 371 
ethnic groups, and tattooing as a custom persists throughout their life, especially in 372 
elderly individuals, as demonstrated by the average age of the persons who were 373 
tattooed (73.33±14.54 years old) being greater than non-tattooed individuals 374 
(47.77±22.41 years old) (t=98.98, P<0.01, t test, data not shown).  However, in terms 375 
of the multivariate analysis, HCV prevalence was not significantly different between 376 
the tattooed and non-tattooed participants.  These inconsistent results may be 377 
attributable to the strong association between age and tattooing (χ2=1.37E2, OR=12.89; 378 
95%CI = 7.57-21.95, P=1.37E-31, chi-square test, data not shown).  Furthermore, 379 
some reports indicate that the male sex is associated with HCV infection39-41.  Our 380 
results lack an association between males and HCV infection, which differs from the 381 
literature on this topic.  One reason for this discrepancy could be that the prevalence 382 
of tattooing in females was significantly higher than in males (female (11.0%) vs male 383 
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(3.4%): χ2=31.50, P<0.01, data not shown), and that the custom of tattooing leads to 384 
higher HCV prevalence (tattooed (20.0%) vs non-tattooed (8.1%): (χ2=21.10, P<0.01, 385 
data not shown)) in females.  386 
The published data reveals that the HCV clearance rate varies in different 387 
populations16.  HCV spontaneous clearance of 18% occurred in children  in a 388 
contemporary US cohort after 6 months of infection42. Two recent studies from north 389 
and southwest China involving a limited number of patients with acute HCV infection 390 
reported recovery rates of 28.2%43 and 30.2%44. The Irish Hepatology Research Group 391 
revealed that there was up to 50% recovery among a population of Irish women who 392 
were exposed to HCV-contaminated anti-D immune globulin45,46. Therefore, the HCV 393 
spontaneous clearance rate in Baisha Li ethnic group is relatively high (42.7 to 56.2%). 394 
There is a possibility that a lower spontaneous clearance rate is masked by fast 395 
progression to disease and HCV-related mortality thus increasing the observed 396 
clearance rate among elderly individuals.  Compared to a population of Chinese 397 
chronically HCV-infected subjects, the significantly lower viral load observed in the Li 398 
population provides indirect evidence to support a higher spontaneous clearance rate 399 
which would correlate with a previous study39.  No significant association was found 400 
with gender in our study, although it has been well-established that women are more 401 
likely to clear HCV than males41,43,44,47. However, three other studies, including U.S. 402 
injection drug users, U.S. blood donors and the Italian general population, also found 403 
no significant association of HCV clearance with gender48. One possible interpretation 404 
for these differing results is that the association with gender may be confounded by 405 
tattooing, the probable route of HCV transmission in Baisha County, which is practiced 406 
significantly more in females than males as discussed above. In addition the genotype 407 
6 strains from our study may differ in this respect compared to the genotypes that 408 
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predominate in other studies that have evidence linking gender and clearance rates. 409 
According to reports, the different HCV spontaneous clearance rates might be related 410 
to host and/or viral factors.  Host factors include humoral and cellular immune 411 
responses.  In this study, only the humoral response was examined, particularly in the 412 
reactivity to individual viral proteins.  From the data collected here, the anti-core 413 
reactivity seemed to persist, while the anti-NS5 reactivity appeared to be short-lived.  414 
It has been reported that reactivity to core protein may represent either non-specific 415 
reactivity or resolved infection with antibodies to other HCV proteins that are no longer 416 
reactive.  In addition, NS3 and core antibodies are the last two remaining reactive 417 
proteins in cases of seroconversion49.   418 
   There is a geographical distribution of the HCV genotypes in China.  For 419 
example, subtypes 1b and 2a were predominant in north China50, subtype 6a was first 420 
found in Guangdong province and transmitted to other regions40, and subtypes 3a and 421 
3b were found in south China51.  Subtype 6a was initially detected in Guangdong 422 
province and has become the second most prevalence subtype since 200822.  423 
Importantly, subtype 6a has rapidly spread from Guangdong to other regions in China 424 
over the past 10 years22.  The distribution of HCV genotypes on Hainan Island which 425 
seceded from Guangdong province in 1988 426 
(http://www.npc.gov.cn/npc/dbdhhy/content_5602.htm), is still largely unknown 427 
especially in the Li ethnic minority.  Fig 3 shows the HCV genotype distribution of 428 
previous studies on Hainan Island from 2009 to 2016; subtype 1b has gradually 429 
decreased, while subtype 6a significantly increased from no detected cases to 35% of 430 
cases in the Han ethnic population24,26,52,53.  Only 6 isolates were from the Li minority, 431 
and interestingly, they were novel gt6 variants20.  According to the above results, we 432 
speculate that there is a different HCV genotype distribution between the Li minority 433 
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and Han ethnic groups on Hainan Island.  We found that novel HCV gt6 predominate 434 
in the Li minority group of Baisha County according to phylogenetic trees constructed 435 
from NS5B and E1 sequences.  The predominant gt6 strains were diverse and did not 436 
cluster into any assigned subtypes from other regions in China, including the rest of 437 
Hainan island24,52,53.  The reason for this discrepancy could be the distinct 438 
geographical location of Li and Han populations or a lack of interaction between the 439 
groups.  In previous studies, samples were collected from the Han population of 440 
Haikou city, a modern city.  Samples in our study were collected from Baisha County, 441 
a remote community, most of whom are of the Li minority.  We concluded that the 442 
broad diversity of gt6 is a likely characteristic of HCV infection in the Li minority group 443 
of Baisha County.  One possible biological interpretation for this tree topology (Fig 1 444 
and Fig 2) is that most of the variants have evolved over time rather than a recent 445 
introduction into Baisha County.  Further support for this hypothesis is that most of 446 
the HCV variants were isolated from elderly (≥60 years) individuals with limited 447 
exposure to HCV transmission routes outside their own community.  A similar 448 
endemic spread seems to have occurred in Ghana, west Africa with gt254.  However, 449 
there is no evolutionary data to support this hypothesis in our current analysis.  450 
Another possible reason is that some isolates were transmitted from Guangdong 451 
province, as KC844040 was the closet sequence from group Ⅳ.  To test these two 452 
hypotheses, comprehensive evolutionary and diversity analyses will be required in a 453 
future study.  Moreover, full-length genome sequencing will be required to provide 454 
more detailed sequence information and meet the requirement of new subtype 455 
designation according to the HCV nomenclature criteria of ICTV27.  456 
 457 
In summary, HCV is common in a rural Li ethnic minority community among its 458 
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older residents (≥60years), demonstrating a birth cohort effect.  Moreover, the anti-459 
HCV confirmatory assay revealed a high rate of spontaneous HCV clearance and 460 
infection in the Baisha Li minority group.  HCV infection within the community is 461 
characterized by the predominance of gt6, with broad genetic diversity that potentially 462 
contains new subtypes for this genotype.  463 
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Supplementary material 636 
 637 
Supplementary Fig 1 Phylogenetic tree of isolates 282, 305 and 409 E1 sequences. 638 
Solid yellow circles, solid green circles and solid red circles represent clones of the 282 639 
isolate, 305 isolate and 409 isolate respectively. A maximum Likelihood tree was 640 
constructed using Mega 7. 641 
 642 
Supplementary table 1 Supplementary table 1 Detailed information of reference 643 
sequences in the phylogenetic analysis 644 
 645 
Supplementary table 2 Details of RIBA reactivity to core, NS3, NS4 andNS5 646 
antigens 647 
 648 
Supplementary table 3 Socio-demographics of subjects according to HCV 649 
Persistent infection and HCV Spontaneous clearance  650 
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Figure legends:  651 
 652 
Fig 1 The estimated maximum likelihood phylogeny for 58 Baisha Li minority 653 
NS5B sequences. Sequences determined in this study are shown in solid green circle.  654 
Solid yellow circle represents unassigned HCV gt6 references which were collected 655 
from China and unassigned reference sequences from other south Asian countries 656 
except China are indicated by solid red circle. Other reference sequences which were 657 
named by subtype and accession number represent assigned HCV gt1-gt7. 658 
 659 
Fig 2 The estimated maximum likelihood phylogeny for 55 Baisha Li minority E1 660 
sequences. Sequences determined in this study are shown in solid green circle.  Solid 661 
yellow circles represent unassigned HCV gt6 references which were collected from 662 
China and unassigned reference sequences from other south Asian countries except 663 
China are indicated by solid red circle. Other reference sequences which were named 664 
by subtype and accession number represent assigned HCV gt1-7. 665 
 666 
Fig 3 The location of Hainan island in China and the HCV genotype distribution 667 
in previous studies.  The Li minority population reside in the central southern 668 
mountainous region (colors) whereas the Han ethic population occupy the northern 669 
coastal region (blank).  670 
Xu 29 
 
29 
 
Table 1 Confirmatory results of HCV antibody by RIBA 671 
 
Both Ortho and Kehua ELISA positive (n=249) ELISA negative, 
RNA negative RNA positive RNA negative, ELISA positive (n=182) 
RIBA positive RIBA indeterminate RIBA negative  
Total Samples = 1682 67 50 36 96 1433 
HCV RNA titer (IU/ml) 6.76x104 (± 9.55) - - - - 
Anti-HCV positive  117§ 153§   
Prevalence of HCV infection  7.0 (117/1682)§ 9.1% (153/1682) §   
Prevalence of HCV spontaneous clearance 42.7 (50/117) §  56.2% (86/153) §   
§ Lower value refers to the exclusion of RIBA indeterminate data and higher value to the 672 
inclusion of RIBA indeterminate data. 673 
 674 
Table 2 Age-related HCV infection in the Baisha Li minority community 675 
ages Anti-HCV (-) (%) Anti-HCV (+) (%) total 
10-20y 293(99.3) 2(0.7) 295 
20-30y 148(100) 0(0) 148 
30-40y 128(100) 0(0) 128 
40-50y 225(99.1) 2(0.9) 227 
50-60y 198(99.5) 1 (0.5) 199 
60-70y 189-190 (89.6–90.0) 21-22 (10.0-10.4) 211 
70-80y 262–284 (76.8–83.3) 57-79(16.7-23.2) 341 
80-95y 86–99 (64.7–74.4) 34-47(25.6-35.3) 133 
total 1529–1565 (90.9–93.0) 117-153(7.0-9.09) 1682 
 676 
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Table 3 Socio-demographics of subjects according to anti-HCV positivity including 677 
RIBA indeterminate results 678 
 Univariate chi-square analysis Multivariate analysis 
 
Anti-HCV(+)§ 
n=153 
Anti–HCV(-) 
n=1529 
OR（95%CI） P-value OR（95%CI） P-value 
Gender       
Male 57(37.3) 597(39.0) 
0.93（0.28-1.28） 0.78 0.73（0.47-1.13） 0.16 
Female 96(62.7) 932(61.0) 
Age       
<60y 5(3.3) 982(64.2) 
0.02（0.01-0.05） 4.11E-54 0.02（0.01-0.05） 6.66E-18 
>60y 148(96.7) 547(35.8) 
Transfusion       
Yes 4(2.6) 25(1.6) 
1.62（0.56-4.73） 0.51 1.17（0.34-3.98） 0.81 
No 149(97.4) 1504(98.4) 
Alcohol 
Consumption 
      
Yes 61(39.9) 614(40.2) 
0.99（0.7-1.39） 0.95 0.97（0.67-1.43） 0.89 
No 92(60.1) 915(59.8) 
Tattooing       
Yes 27(17.6) 108(7.1) 
2.82（1.78-4.46） 1.35E-06 1.01（0.57-1.81） 0.96 
No 126(82.4) 1421(92.9) 
Surgery       
Yes 15(9.8) 40（2.6） 
4.05（2.18-7.51） 1.88E-06 2.75（1.36-5.57） 0.005 
No 138（90.2） 1489（97.4） 
Piercings       
Yes 44(28.8) 382(25) 
1.21（0.84-1.75） 0.31 1.46（0.91-2.35） 0.12 
No 109(71.2) 1147(75) 
Acupuncture   
 
 
   
Yes 4(1.6) 24(2.6) 
1.68（0.58-4.92） 0.34 0.54（0.17-1.72） 0.30 
No 149(98.4) 1505(97.4) 
Family history 
of HCV 
      
Yes 2(1.3) 7（0.5） 
2.88（0.59-13.99） 0.17 1.28(0.23-7.23) 0.78 
No 151(98.7) 1522（99.5） 
Dental 
procedures 
      
Yes 4(2.6) 39(2.6) 
0.98（0.36-2.9） 0.96 0.70(0.22-2.24) 0.55 
No 149(97.4) 1490(97.4) 
 679 
§：HCV RNA positive, RIBA positive and RIBA indeterminate samples 680 
constituted the anti-HCV (+) group 681 
  682 
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Table 4 Socio-demographics of subjects according to anti-HCV positivity excluding 683 
RIBA indeterminate results 684 
 Univariate Chi-square analysis Multivariate analysis 
 
Anti–HCV(+)# 
n=117 
Anti–HCV(-) 
n=1565 
OR（95%CI） P-value OR（95%CI） P-value 
Gender       
Male 44(37.6) 610(39.0) 
0.94（0.64-1.39） 0.77 0.69（0.42-1.12） 0.14 
Female 73(62.4) 955(61.0) 
Age       
<60y 5(4.3) 992(62.4) 
0.03（0.01-0.06） 3.82E-36 0.03（0.01-0.06） 2.39E-15 
>60y 112(95.7) 573(37.6) 
Transfusion       
Yes 3(2.6) 26(1.7) 
1.56（0.46-5.22） 0.47 1.24（0.32-4.82） 0.76 
No 114(97.4) 1539(98.3) 
Alcohol 
consumption 
      
Yes 46(39.3) 629(40.2) 
0.96（0.66-1.42） 0.85 0.96（0.63-1.47） 0.86 
No 71(60.7) 936(59.8) 
Tattooing       
Yes 20(17.1) 115(7.3) 
2.60（1.55-4.36） 1.82E-04 1.01（0.57-1.81） 0.96 
No 97(82.9) 1450(92.7) 
Surgery       
Yes 11(9.4) 44 (2.8) 
3.59（1.80-7.15） 1.11E-04 2.36（1.09-5.10） 0.03 
No 106 (90.6) 1521 (97.2) 
Piercings       
Yes 35(29.9) 391(25) 
1.28（0.85-1.94） 0.24 1.63（0.96-2.75） 0.07 
No 82(70.1) 1174(75) 
Acupuncture   
 
 
   
Yes 4(3.4) 24(1.5) 
2.27（0.78-6.67） 0.12 1.08（0.31-3.70） 0.91 
No 113(96.6) 1541(98.5) 
Family history 
of HCV 
      
Yes 2(1.7) 7(0.4) 3.87（0.80-18.85） 0.07 1.82(0.32-10.27) 0.49 
No 115(98.3) 1558(99.6）     
Dental 
procedures 
      
Yes 2(1.7) 41(2.6) 0.65（0.15-2.71） 0.55 0.37(0.08-1.76) 0.21 
No 115(98.3) 1524(97.4)     
§：HCV RNA positive and RIBA positive samples only constituted the anti-HCV 685 
(+) group 686 
  687 
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Supplementary Table 4  688 
 Male 
n (%) 
Female 
n (%) 
P Value* RIBA 
indeterminate 
results 
HCV(+) 57 (8.7) 96 (9.3) 0.78 Included 
HCV(-) 597 (91.3) 932 (90.7) 
Total 654 1028   
HCV(+) 44 (6.7) 73 (7.1) 0.77 Excluded 
HCV(-) 610 (93.3) 955 (92.9) 
Total 654 1028   
Spontaneous clearance 29 (50.9) 57 (59.4) 0.31 Included 
Persistent infection 28 (49.1) 39 (40.6)  
Total 57 96   
Spontaneous clearance 16 (36.4) 34 (46.6) 0.28 Excluded 
Persistent infection 28 (63.6) 39 (53.4) 
Total 44 73   
* Statistical analysis was performed with a Chi-square test.  689 
 690 
 691 
